Human papillomavirus typing in routine cytological screening: Results of an investigation on 3778 patients;Typage des papillomavirus humains dans les frottis cervicaux de routine. Resultats sur une serie de 3778 patientes

Gynecologie Obstetrique et Fertilite

Volumn 28, Issue 10, 2000, Pages 722-728

  Levert, M ^a   Clavel, C ^a   Graesslin, O ^a   Masure, M ^a   Birembaut, P ^a   Quereux, C ^a   Gabriel, R ^a  

^a REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Cervical intra epithelial neoplasm; Detection cytology; Human papillomavirus

Indexed keywords

ARTICLE; ASSAY; CANCER RISK; COLPOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PREVALENCE; SCREENING; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

EID: 0033769864     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/S1297-9589(00)00011-4     Document Type: Article

References (27)

1. Kurman Human papillomavirus infection of the cervix: Relative risk association of 15 common anogenital types
2. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types
3. HPV typing and testing in gynaecological pathology: Has the time come?
4. Is human papillomavirus testing of value in clinical practice?
5. PCR-based highrisk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears
6. Hybrid capture method for detection of human papillomavirus DNA in clinical specimens
7. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance
8. Evaluation of the Hybrid Capture® human papiliomavirus deoxyribonucleic acid detection test
9. An evaluation of human papillomavirus testing for intermediate and high-risk types as triage before colposcopy
10. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities
11. Sceening for cervical intraepithelial neoplasia grade 2/3: Validity of cytologic study, cervicography and human papillomavirus detection
12. Diagnostic performance of Hybrid Capture® human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study
13. Human papillomavirus DNA detection in cervical specimens by Hybrid Capture®; correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix
14. Different detectability of high-risk HPV in smears from incident and prevalent high-grade squamous intraepithelial lesions of the cervix
15. High-risk human papillomavirus testing of women with cytological low-grade squamous intraepithelial lesions
16. Comparison of PCR- and Hybrid Capture®-based human papillomavirus detection systems using multiple cervical specimen collection strategies
17. Hybrid Capture II®, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I® and PCR results in cervical lesions
18. Detection of genital human papillomavirus infections. Critical review of methods and prevalence studies in relation to cervical cancer
19. Performance of liquid-based, thin-layer cervical cytology: Correlation with reference diagnoses and human papillomavirus testing
20. Homogeneous sampling accounts for the increased diagnostic accuracy using the ThinPrep(TM) processor
21. Hybrid Capture II®-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: A preliminary study on 1 518 women
22. HPV DNA testing in cervical cancer screening: Results from women high-risk province of Costa Rica
23. HPV testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer
24. Human Papillomavirus DNA genotypes : Prognostic factors for progression of cervical intraepithelial neoplasia
25. Assessing gains in diagnostic utility when human papillomavirus testing is used as an adjunct to Papanicolaou smear in the triage of women with cervical cytologic abnormalities
26. Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: A prospective study
27. Type-specific persitence of human papillomavirus DNA before the development of invasive cervical cancer